Injection/Infusion
CONVIDECIA COVID-19 VACCINE (AD5-NCOV-S), RECOMBINANT 0.5ML/DOSE 0.5ML VIAL
Summary
CONVIDECIA COVID-19 VACCINE (AD5-NCOV-S), RECOMBINANT 0.5ML/DOSE 0.5ML VIAL — Injection/Infusion containing Ad5-nCoV-S [recombinant]. Hong Kong Registration No. HK-67825. Certificate Holder: CANSINO BIOLOGICS (HONG KONG) LIMITED. Date of Registration: 02 May, 2023.
Product NameCONVIDECIA COVID-19 VACCINE (AD5-NCOV-S), RECOMBINANT 0.5ML/DOSE 0.5ML VIAL
Registration No.HK-67825
Certificate HolderCANSINO BIOLOGICS (HONG KONG) LIMITED
Holder AddressROOM 1901, 19/F, LEE GARDEN ONE, 33 HYSAN AVENUE, CAUSEWAY BAY, HONG KONG
IngredientsAd5-nCoV-S [recombinant]
Dosage FormInjection/Infusion
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration02 May, 2023
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。